Methylphenidate Hydrochloride recalls

Methylphenidate Hydrochloride products have been recalled 8 times, most recently on 10 Jul 2024. The recalling company is usually Osmotica Pharmaceutical. The most common reason is potency & assay.

Total recalls8since 2017

Last 12 months0reported

Class I00% of total

Ongoing1latest 10 Jul 2024

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 5 63%Class III 3 38%

Why methylphenidate hydrochloride is recalled

Companies

Product types

ADHD Medication8100%

By year

2024113%
2023113%
2022113%
2020225%
2018113%
2017225%

Ongoing methylphenidate hydrochloride recalls

1 active

Reported	Class	Recall	Company	Reason	Where
2 Mar 2022Drug	CLASS II	Methylphenidate Hydrochloride Chewable Tablets, 5 mg recalledMethylphenidate Hydrochloride	Rising Pharmaceuticals	Packaging Defects	Nationwide

All methylphenidate hydrochloride recalls, newest first

8 total

Reported	Class	Recall	Company	Reason	Where
10 Jul 2024Drug	CLASS II	Methylphenidate Hydrochloride, Extended-release Tablets, USP, 36mg recalledMethylphenidate Hydrochloride	Trigen Laboratories	Potency & Assay	Nationwide
2 Aug 2023Drug	CLASS II	Methylphenidate Hydrochloride Tablets, USP 20mg recalledMethylphenidate Hydrochloride	Sun Pharmaceutical Industries	Foreign Material	Nationwide
2 Mar 2022Drug	CLASS II	Methylphenidate Hydrochloride Chewable Tablets, 5 mg recalledMethylphenidate Hydrochloride	Rising Pharmaceuticals	Packaging Defects	Nationwide
19 Feb 2020Drug	CLASS II	Methylphenidate hydrochloride Extended-Release ablets recalledMethylphenidate Hydrochloride	Teva Pharmaceuticals U	Manufacturing (CGMP) Deviations	Nationwide
19 Feb 2020Drug	CLASS II	Methylphenidate hydrochloride Extended-Release ablets recalledMethylphenidate Hydrochloride	Teva Pharmaceuticals U	Manufacturing (CGMP) Deviations	Nationwide
14 Mar 2018Drug	CLASS III	Methylphenidate Hydrochloride Extended-release Tablets, USP, 36 mg recalledMethylphenidate Hydrochloride	Osmotica Pharmaceutical	Potency & Assay	Nationwide
27 Dec 2017Drug	CLASS III	Methylphenidate Hydrochloride Extended-release Tablets, USP 54 mg recalledMethylphenidate Hydrochloride	Osmotica Pharmaceutical	Potency & Assay	Nationwide
27 Dec 2017Drug	CLASS III	Methylphenidate Hydrochloride Extended-release Tablets, USP 27 mg recalledMethylphenidate Hydrochloride	Osmotica Pharmaceutical	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.